Histone deacetylase inhibitor AR‑42 inhibits breast cancer cell growth and demonstrates a synergistic effect in combination with 5‑FU

Ruihao Zhou(Nanchang University), Xiaobin Lv(Nanchang University)
Oncology Letters
May 31, 2018
Cited by 12


Related Papers